small cell lung cancer
Cure51 Partners With Cambridge University Hospitals, Others to Expand Cancer Survival Study to UK
Eight NHS cancer centers will examine tumors from patients with exceptional survival times, focusing on three aggressive cancer types.
German Initiative Making Headway in Improving Lung Cancer Patients' Precision Oncology Access
Premium
The national Network Genomic Medicine Lung Cancer is focused on facilitating molecular profiling-informed treatment to NSCLC patients across 28 partner hospitals in the country.
Merck to Acquire Harpoon Therapeutics for $680M
The deal brings Harpoon's DLL3-targeting agent HPN328, which is currently in Phase I/II trials, into Merck's oncology pipeline.
OncoHost, Hengenix Biotech Exploring Lung Cancer Resistance Biomarkers in Immunotherapy Trial
Researchers will search for biomarkers linked to resistance in small cell lung cancer patients receiving serplulimab with chemotherapy in a Phase III trial.
Puma Biotech IND Cleared to Begin Alisertib Monotherapy Trial in Small Cell Lung Cancer
The Los Angeles-based firm will explore alisertib's efficacy in specific biomarker subgroups in the 60-patient Phase II trial.
Sep 23, 2019